Mérieux Equity Partners (“MxEP”) is pleased to announce that Mérieux Participations 3 has signed an agreement to sell its stake in GTP Bioways (“GTP” or “the Company”), a French company operating as a CDMO (Contract Developing and Manufacturing Organisation) specializing in innovative medicines, to Olon Group, an Italian global leader in the development and production of active pharmaceutical ingredients (APIs).
